Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The dollar's pullback was extended after softer-than-expected core CPI. Euro, Swiss franc, and Japanese yen are firm.

Larger banks are exposed to growing risks. Read why some community banks with conservative models remain safer options.

I discuss adding to an income-focused CEF portfolio monthly, opportunities in volatile market, and holding cash for potential ...

Discover why Morgan Stanley Direct Lending's conservative approach and high dividend yield make it a lucrative option for ...

Concentrated portfolios need periodic rebalancing to avoid value traps. Read about these stock selections to help keep ...

In a challenging market marked by uncertainty, building a resilient portfolio is key to long-term financial stability. Read ...

Google Cloud and AI integration are already working wonders in other areas of Google's ecosystem. Click here to find out why ...

Danaher executed a $4.5 billion share buyback, with an additional 20 million shares authorized. Learn why I remain bullish on ...

With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.

TG Therapeutics' stock rose 15% since my November buy recommendation, driven by Briumvi's strong performance and strategic ...

Stop simply paying your doctor for your visit; get paid when others visit the doctor. Check out two potential avenues to have ...